In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Luke ScarberryDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Garrett ThesingDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0009-0000-5387-5909 Kevin BrennanDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Madison WilliamsDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Matthew K SummersDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-2482-0332 Funding
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3MMechanisms of Spindle Assembly Checkpoint SilencingR01GM108743 · NIGMS · OHIO STATE UNIVERSITY · PI SUMMERS, MATTHEW K · 2014 to 2017
$1.2MDepartment of Radiation Oncology/ The Ohio State University Comprehensive Cancer Center Start-upNCI NIH HHS P30 CA016058NIGMS NIH HHS R01 GM108743NIH HHS P30 CA016058NIH HHS R01 GM108743Pelotonia N/A
6 · The paper itselfAbstract
Indexed as
Alternative SplicingCell Cycle ProteinsM Phase Cell Cycle CheckpointsHumansMad2 ProteinsMaleMitosisProtein BindingProtein IsoformsSpindle ApparatusTestisCell Cycle ProteinsMad2 ProteinsProtein Isoformsalternative splicingcell cyclemitosisspindle assembly checkpoint
Identifiers
PMID40243841
PMCPMC11989133
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390